Conclusion
Health system resources may be triaged accordingly based on clinical features associated with prompt recovery in patients hospitalized for COVID-19. Concurrent antibacterial therapy needs to be judiciously prescribed to minimize the selection of antimicrobial resistance and untoward adverse effects (e.g. C. difficile diarrhea).